eBook
BioAnalytical Strategies for Advanced Therapies
Summary: In this ebook, access expert insight into analytical approaches for traditional biologics, including advanced therapies.
View Now
Offering Fact Sheet
Drug Product Development Services Infocard
Summary: Catalent Biologics provides comprehensive services to meet complex biologic development needs. Click to see our global locations and services...
View Now
Webinars
Best Practices, Strategies & Utilization of Novel Biological Responses for Robust Cell-Based Potency Assays
Watch this webinar to explore how Catalent's robust cell-based potency assays can enhance your research and provide critical data on drug product potency.
View Now
Article
Article: Gene Therapy Is Having A Monumental Year: How Can The Industry Keep Up With Supply?
Summary: Learn about the major achievements in the gene therapy market in 2023, with a focus on reliable manufacturing processes and strategies to enhance predictability while reducing waste in gene therapy manufacturing.
View Now
Podcast
Gene Therapy Is Having A Monumental Year: How Can The Industry Keep Up With Supply?
Summary: Learn about the major achievements in the gene therapy market in 2023, with a focus on reliable manufacturing processes and strategies to enhance predictability while reducing waste in gene therapy manufacturing.
View Now
Executive Summary
In-Line Cell Lysis
Here we present an in-line cell lysis assembly developed at Catalent to increase throughput while controlling critical parameters such as time of contact and solutions ratio, delivering a high-quality product.
View Now
Webinars
Accelerate Your Cell Therapy to Clinic with a Flexible CGMP-Ready Process
This webinar explored the challenges of cell therapy manufacturing and introduced Catalent's UpTempo CAR-T Platform process as a solution.
View Now
Video
JPM Week 2024: Addressing the Latest Market Drivers and Trends for Biologics and Sterile Injectables
Summary: In a recent presentation during the 2024 JP Morgan Healthcare Conference, Catalent’s Group President of Biologics Dave McErlane addresses the latest market drivers for Biologics and Sterile Injectables.
View Now
Executive Summary
Put your AAV on the Fast-Track to the Clinic
In this article, Catalent's experts detail a scalable approach to fast-tracking AAVs with integrated solutions, from clonal cell-lines to market.
View Now
Executive Summary
Overcoming Formulation Challenges for mRNA and High-Concentration Proteins
In this article, experts provide an overview of current challenges associated with high-concentration protein formulations and in formulating mRNA lipid nanoparticles (mRNA-LNP) and how to overcome them.
View Now